Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Janus Kinase 2 (JAK2) V617F mutation in hematological malignancies in México.
Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Ruiz-Delgado GJ, Navarro-Vázquez M, González-Carrillo ML. Ruiz-Argüelles GJ, et al. Rev Invest Clin. 2006 Sep-Oct;58(5):458-61. Rev Invest Clin. 2006. PMID: 17408106
t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience.
Ruiz-Argüelles GJ, Morales-Toquero A, Manzano C, Ruiz-Delgado GJ, Jaramillo P, Gonzalez-Carrillo ML, Reyes-Núñez V. Ruiz-Argüelles GJ, et al. Hematology. 2006 Aug;11(4):235-8. doi: 10.1080/10245330600702893. Hematology. 2006. PMID: 17178661
Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia.
Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Ruiz-Delgado GJ, Rosillo C, Camoriano JK. Ruiz-Argüelles GJ, et al. Am J Hematol. 2007 May;82(5):400-2. doi: 10.1002/ajh.20832. Am J Hematol. 2007. PMID: 17133423
HFE-codon 63/282 (H63D/C282Y) gene variants in Mexican Mestizos are not risk factors for leukemia.
Ruiz-Argüelles GJ, Morales-Toquero A, Cruz-Domínguez G, Reyes-Núñez V, López-Martínez B, Ruiz-Delgado GJ, Garcés-Eisele J. Ruiz-Argüelles GJ, et al. Arch Med Res. 2006 Jan;37(1):65-7. doi: 10.1016/j.arcmed.2005.04.014. Arch Med Res. 2006. PMID: 16314188
Treatment of acute promyelocytic leukemia: a single institution experience.
Ruiz-Argüelles GJ, Morales-Toquero A, Gómez-Rangel JD, López-Martínez B, Ruiz-Delgado GJ, Reyes-Núñez V. Ruiz-Argüelles GJ, et al. Rev Invest Clin. 2005 May-Jun;57(3):415-9. Rev Invest Clin. 2005. PMID: 16187701 Clinical Trial.
Primary thrombophilia in Mexico. V. A comprehensive prospective study indicates that most cases are multifactorial.
Ruiz-Argüelles GJ, López-Martínez B, Valdés-Tapia P, Gómez-Rangel JD, Reyes-Núñez V, Garcés-Eisele J. Ruiz-Argüelles GJ, et al. Am J Hematol. 2005 Jan;78(1):21-6. doi: 10.1002/ajh.20233. Am J Hematol. 2005. PMID: 15609280
More on geographic hematology: the breakpoint cluster regions of the PML/RARalpha fusion gene in Mexican Mestizo patients with promyelocytic leukemia are different from those in Caucasians.
Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Gómez-Rangel JD, Ruiz-Delgado GJ. Ruiz-Argüelles GJ, et al. Leuk Lymphoma. 2004 Jul;45(7):1365-8. doi: 10.1080/10428190310001657344. Leuk Lymphoma. 2004. PMID: 15359634
Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosuppressive, non-myeloablative conditioning regimen: a prospective study in a single institution.
Ruiz-Argüelles GJ, López-Martíneza B, Santellán-Olea MR, Abreu-Díaz G, Reyes-Núñez V, Ruiz-Argüelles A, Garcés-Eisele J. Ruiz-Argüelles GJ, et al. Leuk Lymphoma. 2002 Jul;43(7):1509-11. doi: 10.1080/10428190290033549. Leuk Lymphoma. 2002. PMID: 12389639
The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease.
Ruiz-Argüelles GJ, Rangel JD, Ponce-de-León S, González-Déctor L, Reyes-Núñez V, Garcés-Eisele J. Ruiz-Argüelles GJ, et al. Am J Hematol. 2004 Apr;75(4):200-4. doi: 10.1002/ajh.20026. Am J Hematol. 2004. PMID: 15054809 Clinical Trial.
34 results
Jump to page
Feedback